OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design, synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenyl-6-oxo-1,6-dihydropyrimidine-5-carboxylic acid derivatives as novel xanthine oxidase inhibitors
Qing Mao, Xiwen Dai, Gaoyang Xu, et al.
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111558-111558
Closed Access | Times Cited: 38
Qing Mao, Xiwen Dai, Gaoyang Xu, et al.
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111558-111558
Closed Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications
Nagaraju Kerru, Lalitha Gummidi, Suresh Maddila, et al.
Molecules (2020) Vol. 25, Iss. 8, pp. 1909-1909
Open Access | Times Cited: 1227
Nagaraju Kerru, Lalitha Gummidi, Suresh Maddila, et al.
Molecules (2020) Vol. 25, Iss. 8, pp. 1909-1909
Open Access | Times Cited: 1227
Agents for the Treatment of Gout: Current Advances and Future Perspectives
Xiaoyi Zeng, Yajing Liu, Yuxin Fan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14474-14493
Closed Access | Times Cited: 24
Xiaoyi Zeng, Yajing Liu, Yuxin Fan, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14474-14493
Closed Access | Times Cited: 24
Impact of Synthesized Zero-valance Silver Nanoparticles on Acetylcholinesterase and Xanthine Oxidase: Toxicological and Environmental Implications
Srwa Hashim Mohammed, Ahmed Mahdi Rheima, Dhiey A. Al-aameri, et al.
Case Studies in Chemical and Environmental Engineering (2025), pp. 101095-101095
Open Access | Times Cited: 1
Srwa Hashim Mohammed, Ahmed Mahdi Rheima, Dhiey A. Al-aameri, et al.
Case Studies in Chemical and Environmental Engineering (2025), pp. 101095-101095
Open Access | Times Cited: 1
Recent Progress and Future Perspectives on Anti-Hyperuricemic Agents
Zhiqiang Sun, Xuewen Zhang, Zean Zhao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 19966-19987
Closed Access | Times Cited: 7
Zhiqiang Sun, Xuewen Zhang, Zean Zhao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 22, pp. 19966-19987
Closed Access | Times Cited: 7
Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors
Jun Gao, Xuegui Liu, Bing Zhang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 190, pp. 112077-112077
Closed Access | Times Cited: 44
Jun Gao, Xuegui Liu, Bing Zhang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 190, pp. 112077-112077
Closed Access | Times Cited: 44
Action mechanisms and interaction of two key xanthine oxidase inhibitors in galangal: Combination of in vitro and in silico molecular docking studies
Rongrong Ou, Lianzhu Lin, Mouming Zhao, et al.
International Journal of Biological Macromolecules (2020) Vol. 162, pp. 1526-1535
Closed Access | Times Cited: 40
Rongrong Ou, Lianzhu Lin, Mouming Zhao, et al.
International Journal of Biological Macromolecules (2020) Vol. 162, pp. 1526-1535
Closed Access | Times Cited: 40
Novel N -bridged pyrazole-1-carbothioamides With Potential Antiproliferative Activity: design, synthesis, In Vitro and In Silico Studies
Islam H. El Azab, Essa M. Saied, Alaa A. Osman, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 20, pp. 1743-1766
Closed Access | Times Cited: 32
Islam H. El Azab, Essa M. Saied, Alaa A. Osman, et al.
Future Medicinal Chemistry (2021) Vol. 13, Iss. 20, pp. 1743-1766
Closed Access | Times Cited: 32
Past, present and future of xanthine oxidase inhibitors: design strategies, structural and pharmacological insights, patents and clinical trials
Atamjit Singh, Karanvir Singh, Aman Sharma, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 11, pp. 2155-2191
Closed Access | Times Cited: 11
Atamjit Singh, Karanvir Singh, Aman Sharma, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 11, pp. 2155-2191
Closed Access | Times Cited: 11
Recent Advances in Xanthine Oxidase Inhibitors
Zhi-Gang Sun, Kai-Xiang Wu, Inam Ullah, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 12, pp. 1177-1186
Closed Access | Times Cited: 11
Zhi-Gang Sun, Kai-Xiang Wu, Inam Ullah, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 12, pp. 1177-1186
Closed Access | Times Cited: 11
Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors
Bing Zhang, Yulin Duan, Yuwei Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113928-113928
Closed Access | Times Cited: 24
Bing Zhang, Yulin Duan, Yuwei Yang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113928-113928
Closed Access | Times Cited: 24
Design, synthesis and biological evaluation of 2-[1-(pyridin-2-ylmethyl)-1H-pyrazole-3-carboxamido]benzoic acids as promising urate transporter 1 inhibitors with potential nephroprotective efficacy for the treatment of hyperuricemic nephropathy
Qing Mao, Peng Zhang, Fengwei Lin, et al.
European Journal of Medicinal Chemistry (2025) Vol. 290, pp. 117507-117507
Closed Access
Qing Mao, Peng Zhang, Fengwei Lin, et al.
European Journal of Medicinal Chemistry (2025) Vol. 290, pp. 117507-117507
Closed Access
Novel 3-[4-alkoxy-3-(1H-tetrazol-1-yl) phenyl]-1,2,4-oxadiazol-5(4H)-ones as promising xanthine oxidase inhibitors: Design, synthesis and biological evaluation
Jun Gao, Zhaofeng Zhang, Bing Zhang, et al.
Bioorganic Chemistry (2019) Vol. 95, pp. 103564-103564
Closed Access | Times Cited: 29
Jun Gao, Zhaofeng Zhang, Bing Zhang, et al.
Bioorganic Chemistry (2019) Vol. 95, pp. 103564-103564
Closed Access | Times Cited: 29
Investigation of pyrimidine analogues as xanthine oxidase inhibitors to treat of hyperuricemia and gout through combined QSAR techniques, molecular docking and molecular dynamics simulations
Rahman Abdizadeh, Esfandiar Heidarian, Farzin Hadizadeh, et al.
Journal of the Taiwan Institute of Chemical Engineers (2020) Vol. 113, pp. 72-100
Closed Access | Times Cited: 26
Rahman Abdizadeh, Esfandiar Heidarian, Farzin Hadizadeh, et al.
Journal of the Taiwan Institute of Chemical Engineers (2020) Vol. 113, pp. 72-100
Closed Access | Times Cited: 26
A consensual machine-learning-assisted QSAR model for effective bioactivity prediction of xanthine oxidase inhibitors using molecular fingerprints
Yanling Wu, Menglong Li, Jinru Shen, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2033-2048
Closed Access | Times Cited: 9
Yanling Wu, Menglong Li, Jinru Shen, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 2033-2048
Closed Access | Times Cited: 9
Synthesis and biological evaluation of 2-(4-alkoxy-3-cyano)phenylpyrimidine derivatives with 4-amino or 4-hydroxy as a pharmacophore element binding with xanthine oxidase active site
Ming Sun, Jiaxing Zhao, Qing Mao, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 38, pp. 116117-116117
Closed Access | Times Cited: 17
Ming Sun, Jiaxing Zhao, Qing Mao, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 38, pp. 116117-116117
Closed Access | Times Cited: 17
Synthetic heterocyclic derivatives as promising xanthine oxidase inhibitors: An overview
Gurinder Kaur, Atamjit Singh, Geetakshi Arora, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 3, pp. 443-468
Closed Access | Times Cited: 12
Gurinder Kaur, Atamjit Singh, Geetakshi Arora, et al.
Chemical Biology & Drug Design (2022) Vol. 100, Iss. 3, pp. 443-468
Closed Access | Times Cited: 12
Recent developments in synthetic strategies and pharmacological outcomes of synthetic xanthine oxidase inhibitors: A comprehensive review
Gurinder Kaur, Rajiv Sharma, Ashu Ashu, et al.
Journal of Heterocyclic Chemistry (2024) Vol. 61, Iss. 5, pp. 723-752
Closed Access | Times Cited: 2
Gurinder Kaur, Rajiv Sharma, Ashu Ashu, et al.
Journal of Heterocyclic Chemistry (2024) Vol. 61, Iss. 5, pp. 723-752
Closed Access | Times Cited: 2
Design, synthesis, and biological evaluation of 5-(1H-indol-5-yl)isoxazole-3-carboxylic acids as novel xanthine oxidase inhibitors
Dongqian Huang, Wenye Li, Yilan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116443-116443
Closed Access | Times Cited: 2
Dongqian Huang, Wenye Li, Yilan Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116443-116443
Closed Access | Times Cited: 2
From Xanthine Oxidase Inhibition to In Vivo Hypouricemic Effect: An Integrated Overview of In Vitro and In Vivo Studies with Focus on Natural Molecules and Analogues
João L. Serrano, Joana Figueiredo, Paulo Almeida, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 18
João L. Serrano, Joana Figueiredo, Paulo Almeida, et al.
Evidence-based Complementary and Alternative Medicine (2020) Vol. 2020, Iss. 1
Open Access | Times Cited: 18
N-(3-cyano-1H-indol-5-yl)isonicotinamide and N-(3-cyano-1H-indol-5-yl)-1H-benzo[d]imidazole-5-carboxamide derivatives: Novel amide-based xanthine oxidase inhibitors
Shun Tu, Tingjian Zhang, Yi Zhang, et al.
Bioorganic Chemistry (2021) Vol. 115, pp. 105181-105181
Closed Access | Times Cited: 16
Shun Tu, Tingjian Zhang, Yi Zhang, et al.
Bioorganic Chemistry (2021) Vol. 115, pp. 105181-105181
Closed Access | Times Cited: 16
Design, synthesis and structure-activity relationship of N-phenyl aromatic amide derivatives as novel xanthine oxidase inhibitors
Sen-sen Hu, Tingjian Zhang, Zhaoran Wang, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106403-106403
Closed Access | Times Cited: 6
Sen-sen Hu, Tingjian Zhang, Zhaoran Wang, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106403-106403
Closed Access | Times Cited: 6
Exploration of Novel Xanthine Oxidase Inhibitors Based on 1,6-Dihydropyrimidine-5-Carboxylic Acids by an Integrated in Silico Study
Na Zhai, Chenchen Wang, Fengshou Wu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8122-8122
Open Access | Times Cited: 14
Na Zhai, Chenchen Wang, Fengshou Wu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8122-8122
Open Access | Times Cited: 14
Switching a Xanthine Oxidase Inhibitor to a Dual-Target Antagonist of P2Y1 and P2Y12 as an Oral Antiplatelet Agent with a Wider Therapeutic Window in Rats than Ticagrelor
Yu Lei, Bing Zhang, Dan Liu, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15752-15772
Closed Access | Times Cited: 13
Yu Lei, Bing Zhang, Dan Liu, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15752-15772
Closed Access | Times Cited: 13
A multiscale screening strategy for the identification of novel xanthine oxidase inhibitors based on the pharmacological features of febuxostat analogues
Na Zhai, Yanming Chen, Chenchen Wang, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 14, pp. 6549-6559
Closed Access | Times Cited: 9
Na Zhai, Yanming Chen, Chenchen Wang, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 14, pp. 6549-6559
Closed Access | Times Cited: 9
Novel hybrid isoindole‐1,3(2H)‐dione compounds containing a 1H‐tetrazole moiety: Synthesis, biological evaluation, and molecular docking studies
Ayşe Tan, Serap Kızılkaya, Samir Abbas Ali Noma, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 36, Iss. 5
Closed Access | Times Cited: 9
Ayşe Tan, Serap Kızılkaya, Samir Abbas Ali Noma, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 36, Iss. 5
Closed Access | Times Cited: 9
